Performance supplements

Beta-alanine

Raises muscle carnosine over weeks; tingling is not a measurement of performance or muscle growth.

Human muscle-biopsy and tolerability studies

Beta-alanine molecular structure — Structure reference · C3H7NO2

Practical use

Applying the explained evidence

Where it fits: Raises muscle carnosine over weeks; tingling is not a measurement of performance or muscle growth.
Put the information into practice: Buffering-related capacity, race performance, maximal strength and hypertrophy should be evaluated separately. This entry does not convert a cycling-capacity result into a bodybuilding gain forecast.
Connect evidence to your training: Specify the outcome you want to improve and a repeatable way to measure it. Check whether the study participants, activity and product match the claim; avoid crediting one supplement for changes made alongside several training or diet changes.
Keep this limit in view: The muscle-biopsy and exercise outcomes were separate from sensory effects.

Muscle carnosine and cycling capacity

Sustained-release tolerability experiment

Overview

Beta-alanine supplies a building block for carnosine, an intracellular muscle buffer. Increasing this reservoir is a chronic adaptation; it is different from an immediate stimulant sensation.

Risks and limitations

Paresthesia—tingling or prickling—can occur. A small high-intake trial found mostly low-intensity symptoms, but it was too small and short to settle uncommon harms or long-term laboratory effects.

How to read this

Buffering-related capacity, race performance, maximal strength and hypertrophy should be evaluated separately. This entry does not convert a cycling-capacity result into a bodybuilding gain forecast.

Research explained

Muscle storage and high-intensity capacity

Who was studied

13 supplemented and 12 matched control men; smaller subsets continued to ten weeks and underwent biopsy.

Carnosine increase at four weeks: 58.8 %
Carnosine increase at ten weeks: 80.1 %

What was found

Muscle carnosine rose 58.8% at four weeks and 80.1% at ten weeks. Total work in the fixed high-intensity cycling-capacity test increased 13.0% at four weeks, with a further 3.2% reported at ten.

What it cannot establish

Small, shrinking subsets; capacity to exhaustion is not a timed race or muscle-size endpoint.

Read the original study

Symptoms and blood measurements

Who was studied

19 recreationally trained men; randomized 30-day sustained-release study.

What was found

Tingling was common but generally rated below 3/10. Triglycerides, LDL and urea nitrogen rose within the active group, without significant differences versus the control group.

What it cannot establish

Within-group changes do not establish a treatment effect. This unusual high-intake formulation does not describe every product.

Read the original study

Storage is the relevant mechanism

The biopsy study links accumulated carnosine with work capacity. Skin sensations were not the performance endpoint.

Supporting source

Capacity is task-specific

The test used cycling above maximal aerobic power until exhaustion. A percentage change there is not the same percentage improvement in a sprint, lift or race.

Supporting source

Read the laboratory comparison correctly

A significant before/after change in one arm and no significant between-arm difference are not evidence of a proven lipid effect.

Supporting source

Release form is a variable

The tolerability study tested a specified sustained-release preparation; adverse-event patterns cannot be generalized to every immediate-release blend.

Supporting source